☰

Antonino Passaniti - Publications

Affiliations: 
Biochemistry University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Oncology, Biochemistry
Tree Info Similar researchers PubMed Report error

42 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Passaniti A, Kim MS, Polster BM, Shapiro P. Targeting mitochondrial metabolism for metastatic cancer therapy. Molecular Carcinogenesis. PMID 35723497 DOI: 10.1002/mc.23436  0.317
2019 Blanchard TG, Czinn SJ, Banerjee V, Sharda N, Bafford AC, Mubariz F, Morozov D, Passaniti A, Ahmed H, Banerjee A. Identification of Cross Talk between FoxM1 and RASSF1A as a Therapeutic Target of Colon Cancer. Cancers. 11. PMID 30744076 DOI: 10.3390/Cancers11020199  0.48
2019 Kim MS, Gernapudi R, Cedeno YC, Polster BM, Girnun GD, Passaniti A. Abstract 794: Inhibition of mitochondrial metabolism by a novel agent targeting RUNX2-DNA binding in breast cancer Cancer Research. 79: 794-794. DOI: 10.1158/1538-7445.Am2019-794  0.524
2017 Kim MS, Gernapudi R, Choi EY, Lapidus RG, Passaniti A. Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activity. Oncotarget. 8: 70916-70940. PMID 29050333 DOI: 10.18632/Oncotarget.20200  0.56
2017 Passaniti A, Brusgard JL, Qiao Y, Sudol M, Finch-Edmondson M. Roles of RUNX in Hippo Pathway Signaling. Advances in Experimental Medicine and Biology. 962: 435-448. PMID 28299672 DOI: 10.1007/978-981-10-3233-2_26  0.758
2016 Twum-Ampofo J, Fu DX, Passaniti A, Hussain A, Siddiqui MM. Metabolic targets for potential prostate cancer therapeutics. Current Opinion in Oncology. PMID 26907571 DOI: 10.1097/Cco.0000000000000276  0.305
2016 Li Z, Yang Z, Passaniti A, Lapidus RG, Liu X, Cullen KJ, Dan HC. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation. Oncotarget. PMID 26895469 DOI: 10.18632/Oncotarget.7441  0.397
2016 Kim, Choe M, Cho H, Polster B, Girnun G, Passaniti A. Abstract P5-05-02: Regulation of glucose metabolism by the RUNX2 transcription factor has a negative impact on mitochondrial function in breast cancer cells Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P5-05-02  0.722
2015 Brusgard JL, Choe M, Chumsri S, Renoud K, MacKerell AD, Sudol M, Passaniti A. RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells. Oncotarget. 6: 28132-50. PMID 26320173 DOI: 10.18632/Oncotarget.4654  0.753
2015 Choe M, Brusgard JL, Chumsri S, Bhandary L, Zhao XF, Lu S, Goloubeva OG, Polster BM, Fiskum GM, Girnun GD, Kim MS, Passaniti A. The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells. Journal of Cellular Biochemistry. PMID 25808624 DOI: 10.1002/Jcb.25171  0.759
2015 Mochin MT, Underwood KF, Cooper B, McLenithan JC, Pierce AD, Nalvarte C, Arbiser J, Karlsson AI, Moise AR, Moskovitz J, Passaniti A. Hyperglycemia and redox status regulate RUNX2 DNA-binding and an angiogenic phenotype in endothelial cells. Microvascular Research. 97: 55-64. PMID 25283348 DOI: 10.1016/J.Mvr.2014.09.008  0.676
2015 Mochin MT, Underwood KF, Cooper B, McLenithan JC, Pierce AD, Nalvarte C, Arbiser J, Karlsson AI, Moise AR, Moskovitz J, Passaniti A. Hyperglycemia and redox status regulate RUNX2 DNA-binding and an angiogenic phenotype in endothelial cells Microvascular Research. 97: 55-64. DOI: 10.1016/j.mvr.2014.09.008  0.622
2015 Choe M, Brusgard JL, Chumsri S, Bhandary L, Zhao XF, Lu S, Goloubeva OG, Polster BM, Fiskum GM, Girnun GD, Kim MS, Passaniti A. The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells Journal of Cellular Biochemistry. 116: v. DOI: 10.1002/jcb.25299  0.766
2014 Lillehoj EP, Hyun SW, Feng C, Zhang L, Liu A, Guang W, Nguyen C, Sun W, Luzina IG, Webb TJ, Atamas SP, Passaniti A, Twaddell WS, Puché AC, Wang LX, et al. Human airway epithelia express catalytically active NEU3 sialidase. American Journal of Physiology. Lung Cellular and Molecular Physiology. 306: L876-86. PMID 24658138 DOI: 10.1152/Ajplung.00322.2013  0.356
2013 Underwood KF, Mochin MT, Brusgard JL, Choe M, Gnatt A, Passaniti A. A quantitative assay to study protein:DNA interactions, discover transcriptional regulators of gene expression, and identify novel anti-tumor agents. Journal of Visualized Experiments : Jove. PMID 24022461 DOI: 10.3791/50512  0.732
2013 Di Rosa M, Malaguarnera M, Zanghì A, Passaniti A, Malaguarnera L. Vitamin D3 insufficiency and colorectal cancer. Critical Reviews in Oncology/Hematology. 88: 594-612. PMID 23941729 DOI: 10.1016/J.Critrevonc.2013.07.016  0.314
2013 Underwood KF, Mochin MT, Brusgard JL, Choe M, Gnatt A, Passaniti A. A quantitative assay to study protein: DNA interactions, discover transcriptional regulators of gene expression, and identify novel anti-tumor agents Journal of Visualized Experiments. DOI: 10.3791/50512(2013)  0.765
2012 Cross AS, Hyun SW, Miranda-Ribera A, Feng C, Liu A, Nguyen C, Zhang L, Luzina IG, Atamas SP, Twaddell WS, Guang W, Lillehoj EP, Puché AC, Huang W, Wang LX, ... Passaniti A, et al. NEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia: NEU1 restrains endothelial cell migration, whereas NEU3 does not. The Journal of Biological Chemistry. 287: 15966-80. PMID 22403397 DOI: 10.1074/Jbc.M112.346817  0.398
2012 Lillehoj EP, Hyun SW, Feng C, Zhang L, Liu A, Guang W, Nguyen C, Luzina IG, Atamas SP, Passaniti A, Twaddell WS, Puché AC, Wang LX, Cross AS, Goldblum SE. NEU1 sialidase expressed in human airway epithelia regulates epidermal growth factor receptor (EGFR) and MUC1 protein signaling. The Journal of Biological Chemistry. 287: 8214-31. PMID 22247545 DOI: 10.1074/Jbc.M111.292888  0.393
2012 Underwood KF, D'Souza DR, Mochin-Peters M, Pierce AD, Kommineni S, Choe M, Bennett J, Gnatt A, Habtemariam B, MacKerell AD, Passaniti A. Regulation of RUNX2 transcription factor-DNA interactions and cell proliferation by vitamin D3 (cholecalciferol) prohormone activity. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 27: 913-25. PMID 22189971 DOI: 10.1002/Jbmr.1504  0.729
2012 Pierce AD, Anglin IE, Vitolo MI, Mochin MT, Underwood KF, Goldblum SE, Kommineni S, Passaniti A. Glucose-activated RUNX2 phosphorylation promotes endothelial cell proliferation and an angiogenic phenotype. Journal of Cellular Biochemistry. 113: 282-92. PMID 21913213 DOI: 10.1002/Jcb.23354  0.767
2011 Hyun SW, Anglin IE, Liu A, Yang S, Sorkin JD, Lillehoj E, Tonks NK, Passaniti A, Goldblum SE. Diverse injurious stimuli reduce protein tyrosine phosphatase-μ expression and enhance epidermal growth factor receptor signaling in human airway epithelia. Experimental Lung Research. 37: 327-43. PMID 21649524 DOI: 10.3109/01902148.2011.566673  0.368
2010 Zhang Y, Ali TZ, Zhou H, D'Souza DR, Lu Y, Jaffe J, Liu Z, Passaniti A, Hamburger AW. ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer. Cancer Research. 70: 240-8. PMID 20048076 DOI: 10.1158/0008-5472.Can-09-2904  0.404
2009 D'Souza DR, Salib MM, Bennett J, Mochin-Peters M, Asrani K, Goldblum SE, Renoud KJ, Shapiro P, Passaniti A. Hyperglycemia regulates RUNX2 activation and cellular wound healing through the aldose reductase polyol pathway. The Journal of Biological Chemistry. 284: 17947-55. PMID 19383984 DOI: 10.1074/Jbc.M109.002378  0.439
2009 Liu A, Garg P, Yang S, Gong P, Pallero MA, Annis DS, Liu Y, Passaniti A, Mann D, Mosher DF, Murphy-Ullrich JE, Goldblum SE. Epidermal growth factor-like repeats of thrombospondins activate phospholipase Cgamma and increase epithelial cell migration through indirect epidermal growth factor receptor activation. The Journal of Biological Chemistry. 284: 6389-402. PMID 19129184 DOI: 10.1074/Jbc.M809198200  0.343
2007 Vitolo MI, Anglin IE, Mahoney WM, Renoud KJ, Gartenhaus RB, Bachman KE, Passaniti A. The RUNX2 transcription factor cooperates with the YES-associated protein, YAP65, to promote cell transformation. Cancer Biology & Therapy. 6: 856-63. PMID 17438369 DOI: 10.4161/Cbt.6.6.4241  0.71
2007 Xiao L, Rao JN, Zou T, Liu L, Marasa BS, Chen J, Turner DJ, Passaniti A, Wang JY. Induced JunD in intestinal epithelial cells represses CDK4 transcription through its proximal promoter region following polyamine depletion. The Biochemical Journal. 403: 573-81. PMID 17253961 DOI: 10.1042/Bj20061436  0.514
2006 Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey R, Rosenblum M, Mikkelsen T, Fine HA. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell. 9: 287-300. PMID 16616334 DOI: 10.1016/J.Ccr.2006.03.003  0.36
2006 Qiao M, Shapiro P, Fosbrink M, Rus H, Kumar R, Passaniti A. Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation. The Journal of Biological Chemistry. 281: 7118-28. PMID 16407259 DOI: 10.1074/Jbc.M508162200  0.492
2005 Sui XF, Kiser TD, Hyun SW, Angelini DJ, Del Vecchio RL, Young BA, Hasday JD, Romer LH, Passaniti A, Tonks NK, Goldblum SE. Receptor protein tyrosine phosphatase micro regulates the paracellular pathway in human lung microvascular endothelia. The American Journal of Pathology. 166: 1247-58. PMID 15793303 DOI: 10.1016/S0002-9440(10)62343-7  0.359
2004 Qiao M, Shapiro P, Kumar R, Passaniti A. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway. The Journal of Biological Chemistry. 279: 42709-18. PMID 15304489 DOI: 10.1074/Jbc.M404480200  0.477
2004 Vucenik I, Passaniti A, Vitolo MI, Tantivejkul K, Eggleton P, Shamsuddin AM. Anti-angiogenic activity of inositol hexaphosphate (IP6). Carcinogenesis. 25: 2115-23. PMID 15297368 DOI: 10.1093/Carcin/Bgh232  0.652
2004 Sun L, Vitolo MI, Qiao M, Anglin IE, Passaniti A. Regulation of TGFbeta1-mediated growth inhibition and apoptosis by RUNX2 isoforms in endothelial cells. Oncogene. 23: 4722-34. PMID 15107836 DOI: 10.1038/Sj.Onc.1207589  0.723
2003 Uren A, Merchant MS, Sun CJ, Vitolo MI, Sun Y, Tsokos M, Illei PB, Ladanyi M, Passaniti A, Mackall C, Toretsky JA. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells. Oncogene. 22: 2334-42. PMID 12700668 DOI: 10.1038/Sj.Onc.1206330  0.639
2003 Young BA, Sui X, Kiser TD, Hyun SW, Wang P, Sakarya S, Angelini DJ, Schaphorst KL, Hasday JD, Cross AS, Romer LH, Passaniti A, Goldblum SE. Protein tyrosine phosphatase activity regulates endothelial cell-cell interactions, the paracellular pathway, and capillary tube stability. American Journal of Physiology. Lung Cellular and Molecular Physiology. 285: L63-75. PMID 12626337 DOI: 10.1152/Ajplung.00423.2002  0.378
2001 Park JW, Choi YJ, Suh SI, Baek WK, Suh MH, Jin IN, Min DS, Woo JH, Chang JS, Passaniti A, Lee YH, Kwon TK. Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis. 22: 1633-9. PMID 11577002 DOI: 10.1093/Carcin/22.10.1633  0.327
2001 Sun L, Vitolo M, Passaniti A. Runt-related gene 2 in endothelial cells: Inducible expression and specific regulation of cell migration and invasion Cancer Research. 61: 4994-5001. PMID 11431332  0.412
2001 Park JW, Jang MA, Lee YH, Passaniti A, Kwon TK. P53-independent elevation of p21 expression by pma results from PKC-mediated mRNA stabilization Biochemical and Biophysical Research Communications. 280: 244-248. PMID 11162506 DOI: 10.1006/Bbrc.2000.4105  0.35
2000 Sasaki CY, Lin HC, Passaniti A. Expression of E-cadherin reduces Bcl-2 expression and increases sensitivity to etoposide-induced apoptosis International Journal of Cancer. 86: 660-666. PMID 10797287 DOI: 10.1002/(Sici)1097-0215(20000601)86:5<660::Aid-Ijc9>3.0.Co;2-X  0.389
1999 Sasaki CY, Lin H, Passaniti A. Regulation of urokinase plasminogen activator (uPA) activity by E- cadherin and hormones in mammary epithelial cells Journal of Cellular Physiology. 181: 1-13. PMID 10457348 DOI: 10.1002/(SICI)1097-4652(199910)181:1<1::AID-JCP1>3.0.CO;2-B  0.344
1997 Jiang BH, Agani F, Passaniti A, Semenza GL. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: Involvement of HIF-1 in tumor progression Cancer Research. 57: 5328-5335. PMID 9393757  0.361
1996 Yang C, Chang J, Gorospe M, Passaniti A. Protein tyrosine phosphatase regulation of endothelial cell apoptosis and differentiation Cell Growth and Differentiation. 7: 161-171. PMID 8822199  0.378
Show low-probability matches.